Which breathing aid works best for tiny preemies? new study compares two methods.
NCT ID NCT04698473
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 85 very premature babies (24-29 weeks) with breathing problems to compare two types of non-invasive breathing support: nasal CPAP and nasal IPPV. Both methods deliver surfactant (a lung treatment) without a breathing tube. The goal was to see which method reduces the need for a breathing machine within 72 hours. The study found no clear winner, but helps doctors understand options for these fragile infants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY DISTRESS SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hilal Ozkan
Bursa, Select..., 16285, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can gentle oscillations help premature babies breathe better?
- Could a tiny tube spare preterm babies from breathing machines?
- Can an Oxygen-Boosting drug help when all else fails?
- Can a steroid shot into the windpipe protect preemies' lungs?
- Experimental 'Storm Stopper' therapy tested for COVID-19, flu, and RSV
- Simple bedside ultrasound may spot lung risk in preemies